)
Quoin Pharmaceuticals (QNRX) investor relations material
Quoin Pharmaceuticals Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Special meeting set for Nov. 12, 2026; record date Sept. 23, 2026. Board recommends FOR both proposals.
Main item would let private-placement warrant holders raise beneficial ownership and voting limits from 4.99% to no more than 9.99%, subject to written notice.
Voting matters and shareholder proposals
Proposal 1 covers warrants issued in the Oct. 2025 and Aug. 2026 private placements; any limit increase takes effect on the 61st day after notice.
Proposal 2 would permit adjournment to seek additional votes if needed; approval of each proposal requires a majority of votes cast, with abstentions excluded.
Quorum requires at least two shareholders representing 33.5% of voting power; a reconvened meeting may proceed with any shareholders present if quorum is again absent.
Board of directors and corporate governance
The Board recommends FOR Proposals 1 and 2; Dr. Michael Myers serves as Board chair and CEO.
Dennis Langer, Michael Myers, Denise Carter, Sally Lawlor and James Culverwell participated in one or both private placements.
- Shareholders will vote on raising beneficial ownership limits for private placement investors.QNRX
Proxy filing - Registering 9.4M ADSs for resale may cause major dilution; proceeds fund rare disease R&D.QNRX
Registration filing - Net loss widened, clinical progress continued, and funding is expected to last into 2027.QNRX
Q2 2026 - Shareholders will vote on board elections, compensation, 401(k) changes, and auditor appointment.QNRX
Proxy filing - Shareholders will vote on director elections, compensation changes, and auditor appointment at the 2026 AGM.QNRX
Proxy filing - Q1 2026 net loss reached $5M, with $14M cash and urgent need for new funding.QNRX
Q1 2026 - QRX003 shows strong efficacy for Netherton Syndrome, with pivotal trials and global expansion ahead.QNRX
Corporate presentation - Advanced QRX003 and pipeline, secured $104.5M financing, and expects funding into 2027.QNRX
Q4 2025 - Registering 10M+ ADSs for resale may cause major dilution but could raise $88.7M for R&D.QNRX
Registration Filing
Next Quoin Pharmaceuticals earnings date
Next Quoin Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage
)